Stay updated on LATITUDE Study: Daily Long-Acting Therapy Clinical Trial
Sign up to get notified when there's something new on the LATITUDE Study: Daily Long-Acting Therapy Clinical Trial page.

Latest updates to the LATITUDE Study: Daily Long-Acting Therapy Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference0.4%
- Check19 days agoChange DetectedThe web page has been updated from version 2.16.2 to version 2.16.3.SummaryDifference0.0%
- Check26 days agoChange DetectedThe web page has been updated from version v2.16.1 to v2.16.2.SummaryDifference0.0%
- Check33 days agoChange DetectedThe web page has been updated to reflect the upcoming modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an invitation for API users to provide input. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.SummaryDifference0.5%
- Check62 days agoChange DetectedThe web page has been updated to reflect the latest study protocol changes, including the cessation of randomization into Step 2 and the transition of participants to long-acting antiretroviral therapy (LA-ART) based on recommendations from the Data Safety and Monitoring Board. Additionally, the study's purpose and methodology have been clarified, emphasizing the comparison of LA-ART and standard of care for HIV treatment.SummaryDifference100%
- Check76 days agoChange DetectedThe web page has undergone significant updates, including the addition of new drug information related to HIV treatment, specifically the RPV-LA and CAB-LA loading and maintenance doses, as well as the involvement of ViiV Healthcare as a collaborator. Additionally, the revision number has been updated from v2.14.4 to v2.15.0.SummaryDifference46%
Stay in the know with updates to LATITUDE Study: Daily Long-Acting Therapy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the LATITUDE Study: Daily Long-Acting Therapy Clinical Trial page.